Association of ABCB1, 5-HT3B Receptor and CYP2D6 Genetic Polymorphisms with Ondansetron and Metoclopramide Antiemetic Response in Indonesian Cancer Patients Treated with Highly Emetogenic Chemotherapy

Author(s):
Perwitasari, D.A.; Wessels, J.A.M.; Straaten, R.J.H.M. van der; Baak-Pablo, R.F.; Mustofa, M.; Hakimi, M.; Nortier, J.W.R.; Gelderblom, H.; Guchelaar, H.J. (0000-0002-7085-1383)
Published
2011
Publication type
Article / Letter to editor
pharmacogeneticsantiemeticschemotherapycancerIndonesia
Date issued
2011-10-31
Language
English
Is part of
Japanese Journal of Clinical Oncology (2011), Vol. 41, no. 10, p. 1168-1176
hdl
1887/110850
doi
10.1093/jjco/hyr117